Robert W Postma - 29 Nov 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
29 Nov 2022
Net transactions value
+$487,500
Form type
4
Filing time
01 Dec 2022, 15:05:19 UTC
Previous filing
24 Jun 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $487,500 +750,000 +18% $0.6500 5,000,000 29 Nov 2022 By WaterMill Asset Management Corp. F1, F2
holding TCRT Common Stock 1,241,870 29 Nov 2022 Direct F3
holding TCRT Common Stock 3,574 29 Nov 2022 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp.
F2 The shares were purchased in a registered underwritten offering on November 29, 2022.
F3 Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.